Company intelligence / Profile preview

Sigma-Aldrich

Burlington, Massachusetts, United Statessigmaaldrich.com ↗

Ownership: Private
Employees: ~9600
Development stage: Commercial

Overview

Sigma-Aldrich does not conduct clinical trials or have clinical results. It provides chemicals, reagents, and custom manufacturing services to support life sciences R&D and pharmaceutical production.

Modalities: Small moleculeBiologicRecombinant proteinAntibodyPeptidesNucleic acids
Industry: Contract Manufacturing Organization

Partnerships

Sangamo BioSciences (zinc finger-based lab reagents)Numerous collaborations with academic consortia such as The RNAi Consortium at MIT/Harvard/Eli Lilly

Beyond the preview

Go deeper on Sigma-Aldrich.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sigma-Aldrich.

Explore the full profile